Medically reviewed by Mary Choy, PharmD Your kidneys may be small in size, but they play an important role in the body.

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

When the U.S. Food and Drug Administration (FDA) approved rosuvastatin, early reports indicated that it could cause blood ...

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...

Aspirin use is associated with an increased risk for acute kidney injury in critical patients with chest trauma, whereas ...

The regulatory body approved the drug for the treatment of adults with C3 glomerulopathy (C3G) to reduce proteinuria. C3G is a progressive and ultra-rare kidney disease that is typically diagnosed ...

Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...

Anyone who has diabetes, high blood pressure, heart problems or has a family history of the disease is at increased risk for ...

According to the CDC, around 37 million American adults have chronic kidney disease, and millions more are at risk of developing it.

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...

Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...